| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Glioma | D005910 | 112 associated lipids |
(e,z)-farnesol
(e,z)-farnesol is a lipid of Prenol Lipids (PR) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 3613 references associated with (e,z)-farnesol in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for (e,z)-farnesol
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with (e,z)-farnesol
PubChem Biomolecular Interactions and Pathways
All references with (e,z)-farnesol
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:27357648 | ||||
| pmid:27239017 | ||||
| pmid:27138105 | ||||
| pmid:26992462 | ||||
| pmid:26972663 | ||||
| pmid:26968084 | ||||
| pmid:26923572 | ||||
| pmid:26905659 | ||||
| pmid:26669506 | ||||
| pmid:26626450 | ||||
| pmid:26546815 | ||||
| pmid:26442918 | ||||
| pmid:26365385 | ||||
| pmid:26341906 | ||||
| pmid:26318416 | ||||
| pmid:26162644 | ||||
| pmid:25935694 | ||||
| pmid:25894100 | ||||
| pmid:25882299 | ||||
| pmid:25810363 | ||||
| pmid:25739905 | ||||
| pmid:25735913 | ||||
| pmid:25697480 | ||||
| pmid:25624157 | ||||
| pmid:26143865 | ||||
| pmid:25542266 | ||||
| pmid:25541558 | ||||
| pmid:25535203 | ||||
| pmid:25468257 | ||||
| pmid:25460024 | ||||
| pmid:25043275 | ||||
| pmid:24895430 | ||||
| pmid:24848877 | ||||
| pmid:24762323 | ||||
| pmid:24704370 | ||||
| pmid:24691869 | ||||
| pmid:24584843 | ||||
| pmid:24444894 | ||||
| pmid:24435839 | ||||
| pmid:14296566 | ||||
| pmid:29380558 | ||||
| pmid:29181599 | ||||
| pmid:28684169 | ||||
| pmid:28584159 | ||||
| pmid:28471040 | ||||
| pmid:28329720 | ||||
| pmid:28192189 | ||||
| pmid:27021020 | ||||
| pmid:26198568 | ||||
| pmid:25976810 | ||||
| pmid:25261400 | ||||
| pmid:28622460 | ||||
| pmid:28603849 | ||||
| pmid:28285658 | ||||
| pmid:28284180 | ||||
| pmid:28043124 | ||||
| pmid:27987234 | ||||
| pmid:27796932 | ||||
| pmid:27665610 | ||||
| pmid:27623739 | ||||
| pmid:27440491 | ||||
| pmid: | ||||
| Chen Y et al. | Targeted delivery of curcumin to tumors via PEG-derivatized FTS-based micellar system. | 2014 | AAPS J | pmid:24706375 |
| Horev B et al. | pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. | 2015 | ACS Nano | pmid:25661192 |
| Lochnit G and Geyer R | Evidence for the presence of the Kennedy and Bremer- Greenberg pathways in Caenorhabditis elegans. | 2003 | Acta Biochim. Pol. | pmid:14740010 |
| Sun J et al. | A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel. | 2016 | Acta Biomater | pmid:27422196 |
| Chagas CE et al. | Farnesol inhibits cell proliferation and induces apoptosis after partial hepatectomy in rats. | 2009 Sep-Oct | Acta Cir Bras | pmid:19851690 |
| Epplen R et al. | Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. | 2011 | Acta Oncol | pmid:20429730 |
| Koo H and Jeon JG | Naturally occurring molecules as alternative therapeutic agents against cariogenic biofilms. | 2009 | Adv. Dent. Res. | pmid:19717411 |
| Koo H | Strategies to enhance the biological effects of fluoride on dental biofilms. | 2008 | Adv. Dent. Res. | pmid:18694872 |
| Lakshman R et al. | Use of CYP2E1-transfected human liver cell lines in elucidating the actions of ethanol. | 2005 | Alcohol. Clin. Exp. Res. | pmid:16205373 |
| Corsini A et al. | Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. | 1995 | Am. J. Cardiol. | pmid:7604791 |
| Gomes F et al. | Farnesol as antibiotics adjuvant in Staphylococcus epidermidis control in vitro. | 2011 | Am. J. Med. Sci. | pmid:21107231 |
| Chana RS and Brunskill NJ | Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma. | 2006 | Am. J. Nephrol. | pmid:16508249 |
| Blazer-Yost BL et al. | Protein prenylation is required for aldosterone-stimulated Na+ transport. | 1997 | Am. J. Physiol. | pmid:9227422 |
| Weissmann N et al. | Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. | 1999 | Am. J. Physiol. | pmid:9887060 |
| Vandewaa EA et al. | Physiological role of HMG-CoA reductase in regulating egg production by Schistosoma mansoni. | 1989 | Am. J. Physiol. | pmid:2782464 |
| Goto T et al. | Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways. | 2011 | Am. J. Physiol. Endocrinol. Metab. | pmid:21862726 |
| Banke TG et al. | Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation. | 2010 | Am. J. Physiol., Cell Physiol. | pmid:20457836 |
| Rubins JB et al. | Lovastatin induces apoptosis in malignant mesothelioma cells. | 1998 | Am. J. Respir. Crit. Care Med. | pmid:9603146 |
| Mohamed MA et al. | Polyacrylamide gel miniaturization improves protein visualization and autoradiographic detection. | 1989 | Anal. Biochem. | pmid:2729547 |
| Saisho Y et al. | Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. | 1997 | Anal. Biochem. | pmid:9324945 |
| Cardemil E et al. | Separation of isoprenoid alcohols and aldehydes by thin-layer chromatography. | 1974 | Anal. Biochem. | pmid:4838788 |
| Song L | Detection of farnesyl diphosphate accumulation in yeast ERG9 mutants. | 2003 | Anal. Biochem. | pmid:12758256 |
| Ellsworth RK and Nowak CA | A gas chromatographic-mass spectrometric analysis of the esterifying alcohols of pumpkin seed protochlorophylls. | 1974 | Anal. Biochem. | pmid:4362215 |
| Derengowski LS et al. | Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. | 2009 | Ann. Clin. Microbiol. Antimicrob. | pmid:19402910 |
| Rhome R and Del Poeta M | Lipid signaling in pathogenic fungi. | 2009 | Annu. Rev. Microbiol. | pmid:19450140 |
| Meinhardt G et al. | Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells. | 2002 | Anticancer Drugs | pmid:12187329 |
| Santen RJ et al. | Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells. | 2006 | Anticancer Drugs | pmid:16317288 |
| Costa CB et al. | Farnesyltransferase inhibitors: molecular evidence of therapeutic efficacy in acute lymphoblastic leukemia through cyclin D1 inhibition. | 2012 | Anticancer Res. | pmid:22399601 |
| Shirtliff ME et al. | Farnesol-induced apoptosis in Candida albicans. | 2009 | Antimicrob. Agents Chemother. | pmid:19364863 |
| Chen F et al. | Tooth-binding micelles for dental caries prevention. | 2009 | Antimicrob. Agents Chemother. | pmid:19704121 |
| Langford ML et al. | Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions. | 2010 | Antimicrob. Agents Chemother. | pmid:19933803 |
| Sharma M and Prasad R | The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans. | 2011 | Antimicrob. Agents Chemother. | pmid:21768514 |
| Brilhante RS et al. | Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei. | 2012 | Antimicrob. Agents Chemother. | pmid:22290941 |
| Rossignol T et al. | Transcriptional response of Candida parapsilosis following exposure to farnesol. | 2007 | Antimicrob. Agents Chemother. | pmid:17684006 |
| Hornby JM et al. | Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B. | 2003 | Antimicrob. Agents Chemother. | pmid:12821501 |
| Cao YY et al. | cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. | 2005 | Antimicrob. Agents Chemother. | pmid:15673737 |
| Brehm-Stecher BF and Johnson EA | Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. | 2003 | Antimicrob. Agents Chemother. | pmid:14506058 |
| Falsetta ML et al. | Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo. | 2012 | Antimicrob. Agents Chemother. | pmid:22985885 |